The global thermoluminescent dosimeter (TLD) services market was valued at $405.9 million in 2018, and is projected to reach $1335.9 million by 2026, registering a CAGR of 17.1% from 2019 to 2026. A thermoluminescent dosimeter (TLD) is a device that measures quantity of radiations emitting from radioactive materials, absorbed doses, equivalent doses, and other related statistics. On exposure of TLD to radiations discharged from industries or power plants, the electrons in the dosimetry system get triggered and gain high energy, thereby providing radiation measurements. On heating, the electrons in the dosimeter regain their original ground state and emit light, which will be measured by utilizing a specialized detector. This emitted light output is directly proportional to the radiation exposure, and the measurement is provided accordingly. Thus, this technique assists in quantitative measurement of gamma, beta radiations, and X-rays. As a result, of which, dosimeters majorly find their application in radiation metrology, experimental nuclear physics, medical safety & security, and nuclear power facilities. Dosimetry service providers have the competencies to provide the reading, interpretation, and calibration of devices for measuring the radioactivity in biological samples, human body, or in assessing radiation doses.
Rise in demand for dosimeters in medical industries for treating cancer patients is one of the major factors responsible for the growth of the market. As per the data published by the Cancer Research UK Organization, 17 million new cases of cancer and 9.6 million deaths were recorded in 2018, globally. Furthermore, as per their estimates, every year nearly 27.5 million new cancer cases will be registered until 2040. Such increase in prevalence of cancer is expected to propel the demand for dosimeters globally. Moreover, upsurge in use of radioactive materials in the fields of research, defense sector, and power production significantly contributes toward the growth of the global TLD services market. Furthermore, key players operating in the market are investing in developing devices that are capable of measuring radioactivity in premises of nuclear power plants, thereby boosting the growth of market across the globe. As per the data published by the World Nuclear Association, 395 civil nuclear power reactors are operating presently worldwide, along with 53 under construction. This is expected to boost the demand for dosimeters used in radiation dose monitoring for nuclear facilities. Moreover, increase in awareness among workers about the health hazards associated with harmful radiations is fueling the market growth.
The global TLD services market is segmented into type, industry, dosimetry services, and region. Depending on type, the market is classified into calcium fluoride TLD and lithium fluoride TLD. As per industry, it is fragmented into nuclear industries, medical industries, research institutions, safety & security industries, health physics industries, and mining industries. On the basis of dosimetry services, it is classified into whole-body X-ray badges, extremity dosimetry, environmental/area dosimetry, and other services. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Some of the key players operating in the global TLD services market include Mirion Technologies, Inc., MP Biomedicals, SABS, Landauer, Radiation Detection Company, Sierra Radiation, PL Medical, AEIL of the Southwest, Inc., and Thermo Fisher Scientific, Inc.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis along with the current global thermoluminescent dosimeter (TLD) services market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment
The market forecast is studied from 2019 to 2026
The market size and estimations are based on a comprehensive analysis of key developments in the industry
A qualitative analysis based on innovative products facilitates strategic business planning
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
KEY MARKET SEGMENTS
By Type
o Calcium fluoride TLD
o Lithium fluoride TLD
By Industry
o Nuclear
o Medical
o Research institutions
o Safety & security industries
o Health physics applications
o Mining
By Dosimetry service
o Whole body X-ray badges
o Extremity dosimetry
o Environmental/area dosimetry
o Other services
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o Spain
o Italy
o UK
o Rest of Europe
Asia-Pacific
o Japan
o India
o China
o Australia
o South Korea
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
KEY MARKET PLAYERS
IBA Dosimetry GmbH
LANDAUER
Mirion Technologies, Inc.
MP Biomedicals
Sierra Radiation Dosimetry Service, Inc.
South African Bureau of Standards (SABS)
Thermo Fisher Scientific, Inc.
Netcare Limited
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in demand for dosimeters in medical industries for cancer treatments
3.3.1.2.Surge in awareness regarding occupational safety
3.3.2.Restraint
3.3.2.1.Availability of potent alternatives
3.3.3.Opportunity
3.3.3.1.Upsurge in number of nuclear power plants to meet energy demands
CHAPTER 4:THERMOLUMINESCENT DOSIMETER SERVICES MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.1.Calcium fluoride (CaF2) TLD
4.1.1.Key market trends, growth factors, and opportunities
4.1.2.Market size and forecast
4.1.3.Market analysis, by country
4.1.Lithium fluoride (LiF) TLD
4.1.1.Key market trends, growth factors, and opportunities
4.1.2.Market size and forecast
4.1.3.Market analysis, by country
CHAPTER 5:THERMOLUMINESCENT DOSIMETER (TLD) SERVICES MARKET, BY INDUSTRY
5.1.Overview
5.1.1.Market size and forecast
5.1.Nuclear industry
5.1.1.Market size and forecast
5.1.2.Market analysis, by country
5.1.Medical industry
5.1.1.Market size and forecast
5.1.2.Market analysis, by country
5.1.Research institutions
5.1.1.Market size and forecast
5.1.2.Market analysis, by country
5.1.Safety & security industries
5.1.1.Market size and forecast
5.1.2.Market analysis, by country
5.1.Health physics applications
5.1.1.Market size and forecast
5.1.2.Market analysis, by country
5.2.Mining
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
CHAPTER 6:GLOBAL THERMOLUMINESCENT DOSIMETER (TLD) SERVICES MARKET, BY DOSIMETRY SERVICE
6.1.Overview
6.1.1.Market size and forecast
6.1.Whole-body X-ray badges
6.1.1.Market size and forecast
6.1.2.Market analysis, by country
6.1.Extremity dosimetry
6.1.1.Market size and forecast
6.1.2.Market analysis, by country
6.1.Environmental/area dosimetry
6.1.1.Market size and forecast
6.1.2.Market analysis, by country
6.1.Other services
6.1.1.Market size and forecast
6.1.2.Market analysis, by country
CHAPTER 7:THERMOLUMINESCENT DOSIMETER (TLD) SERVICES, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key trends and opportunities
7.2.2.North America market size and forecast, by country
7.2.3.North America market size and forecast, by type
7.2.4.North America market size and forecast, by industry
7.2.5.North America market size and forecast, by dosimetry services
7.2.6.U.S.
7.2.6.1.U.S. market size and forecast, by type
7.2.6.2.U.S. market size and forecast, by industry
7.2.6.3.U.S. market size and forecast, by dosimetry services
7.2.7.Canada
7.2.7.1.Canada market size and forecast, by type
7.2.7.2.Canada market size and forecast, by industry
7.2.7.3.Canada market size and forecast, by dosimetry services
7.2.8.Mexico
7.2.8.1.Mexico market size and forecast, by type
7.2.8.2.Mexico market size and forecast, by industry
7.2.8.3.Mexico market size and forecast, by dosimetry services
7.3.Europe
7.3.1.Key trends and opportunities
7.3.2.Europe market size and forecast, by country
7.3.3.Europe market size and forecast, by type
7.3.4.Europe market size and forecast, by industry
7.3.5.Europe market size and forecast, by dosimetry services
7.3.6.Germany
7.3.6.1.Germany market size and forecast, by type
7.3.6.2.Germany market size and forecast, by industry
7.3.6.3.Germany market size and forecast, by dosimetry services
7.3.7.UK
7.3.7.1.UK market size and forecast, by type
7.3.7.2.UK market size and forecast, by industry
7.3.7.3.UK market size and forecast, by dosimetry services
7.3.8.Spain
7.3.8.1.Spain market size and forecast, by type
7.3.8.2.Spain market size and forecast, by industry
7.3.8.3.Spain market size and forecast, by dosimetry services
7.3.9.France
7.3.9.1.France market size and forecast, by type
7.3.9.2.France market size and forecast, by industry
7.3.9.3.France market size and forecast, by dosimetry services
7.3.10.Italy
7.3.10.1.Italy market size and forecast, by type
7.3.10.2.Italy market size and forecast, by industry
7.3.10.3.Italy market size and forecast, by dosimetry services
7.3.11.Rest of Europe
7.3.11.1.Rest of Europe market size and forecast, by type
7.3.11.2.Rest of Europe market size and forecast, by industry
7.3.11.3.Rest of Europe market size and forecast, by dosimetry services
7.4.Asia-Pacific
7.4.1.Key trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by type
7.4.4.Asia-Pacific market size and forecast, by industry
7.4.5.Asia-Pacific market size and forecast, by dosimetry services
7.4.6.Japan
7.4.6.1.Japan market size and forecast, by type
7.4.6.2.Japan market size and forecast, by industry
7.4.6.3.Japan market size and forecast, by dosimetry services
7.4.7.China
7.4.7.1.China market size and forecast, by type
7.4.7.2.China market size and forecast, by industry
7.4.7.3.China market size and forecast, by dosimetry services
7.4.8.India
7.4.8.1.India market size and forecast, by type
7.4.8.2.India market size and forecast, by industry
7.4.8.3.India market size and forecast, by dosimetry services
7.4.9.Australia
7.4.9.1.Australia market size and forecast, by type
7.4.9.2.Australia market size and forecast, by industry
7.4.9.3.Australia market size and forecast, by dosimetry services
7.4.10.South Korea
7.4.10.1.South Korea market size and forecast, by type
7.4.10.2.South Korea market size and forecast, by industry
7.4.10.3.South Korea market size and forecast, by dosimetry services
7.4.11.Rest of Asia-Pacific
7.4.11.1.Rest of Asia-Pacific market size and forecast, by type
7.4.11.2.Rest of Asia-Pacific market size and forecast, by industry
7.4.11.3.Rest of Asia-Pacific market size and forecast, by dosimetry services
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.3.LAMEA market size and forecast, by type
7.5.4.LAMEA market size and forecast, by industry
7.5.5.LAMEA market size and forecast, by dosimetry services
7.5.6.Brazil
7.5.6.1.Brazil market size and forecast, by type
7.5.6.2.Brazil market size and forecast, by industry
7.5.6.3.Brazil market size and forecast, by dosimetry services
7.5.7.South Africa
7.5.7.1.South Africa market size and forecast, by type
7.5.7.2.South Africa market size and forecast, by industry
7.5.7.3.South Africa market size and forecast, by dosimetry services
7.5.8.Saudi Arabia
7.5.8.1.Saudi Arabia market size and forecast, by type
7.5.8.2.Saudi Arabia market size and forecast, by industry
7.5.8.3.Saudi Arabia market size and forecast, by dosimetry services
7.5.9.Rest of LAMEA
7.5.9.1.Rest of LAMEA market size and forecast, by type
7.5.9.2.Rest of LAMEA market size and forecast, by industry
7.5.9.3.Rest of LAMEA market size and forecast, by dosimetry services
CHAPTER 8:COMPANY PROFILE
8.1.IBA DOSIMETRY
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Service portfolio
IBA Dosimetry offers the following services:
8.1.5.Business performance
8.2.LANDAUER
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Service portfolio
8.3.MIRION TECHNOLOGIES, INC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Service portfolio
8.3.5.Key strategic moves and developments
8.4.MP BIOMEDICALS
8.4.1.Company overview
8.4.2.Operating business segments
8.4.3.Service portfolio
8.5.NETCARE LIMITED
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Business performance
8.5.5.Operating business segments
8.5.6.Service portfolio
8.5.7.Key strategic moves and developments
8.6.SIERRA RADIATION DOSIMETRY SERVICE, INC.
8.6.1.Company overview
8.6.2.Operating business segments
8.6.3.Service portfolio
8.7.SOUTH AFRICAN BUREAU OF STANDARDS (SABS)
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Business performance
8.7.4.Service portfolio
8.8.THERMO FISHER SCIENTIFIC, INC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Service portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments